•
China-based Shanghai BioScience Co., Ltd., a life sciences service platform, announced the completion of a new financing round, raising RMB 100 million (USD 13.73 million). The funding round was solely led by HUAGAI Capital. The proceeds will be used to accelerate the construction of independent brand product lines through mergers…